Daicel Corporation

4202.T · Tokyo Stock Exchange · JPY

1.620,00JPY

+25,00 (+1,57 %)Stand 10. Nov., 2:30

Vortag 1.595,00

Kennzahlen

Eröffnung
1.613,00
Vortag
1.595,00
Tagesspanne
1.602,50 – 1.632,00
52 Wochen
1.112,50 – 1.658,00
Volumen
572.500
Ø Volumen
1,21 Mio.
Börsenwert
369,66 Mrd. ¥
KGV
41,4
Gewinn je Aktie (TTM)
39,11
Dividendenrendite
4,0 %
Beta
0,5
Nächste Zahlen
3. Feb. 2027

Finanzen

JPYFY 2026FY 2025FY 2024FY 2023FY 2022
Umsatz579,63 Mrd.586,53 Mrd.558,06 Mrd.538,03 Mrd.467,94 Mrd.
Herstellungskosten433,34 Mrd.420,69 Mrd.397,67 Mrd.390,98 Mrd.328,26 Mrd.
Bruttogewinn146,29 Mrd.165,84 Mrd.160,39 Mrd.147,04 Mrd.139,68 Mrd.
Forschung und Entwicklung025,93 Mrd.23,39 Mrd.21,88 Mrd.20,74 Mrd.
Vertrieb und Verwaltung104,22 Mrd.78,9 Mrd.74,6 Mrd.77,66 Mrd.68,24 Mrd.
Operatives Ergebnis42,07 Mrd.61,01 Mrd.62,39 Mrd.47,51 Mrd.50,7 Mrd.
EBITDA72,71 Mrd.108,86 Mrd.111,4 Mrd.87,98 Mrd.75,84 Mrd.
Nettogewinn10,18 Mrd.49,48 Mrd.55,84 Mrd.40,68 Mrd.31,25 Mrd.
Gewinn je Aktie (verwässert)38,74181,44197,56138,87104,14

Bewertung

Letzte 12 Monate

KGV
41,4
Kurs-Umsatz-Verhältnis
0,6
Kurs-Buchwert-Verhältnis
1,1
PEG
-0,6
Bruttomarge
25,0 %
Operative Marge
7,3 %
Nettomarge
1,7 %
Verschuldungsgrad
0,8
EV/EBITDA
8,3
Eigenkapitalrendite
2,7 %
Kapitalrendite (ROIC)
2,4 %
Free-Cashflow-Rendite
0,0 %
FY 2026FY 2025FY 2024FY 2023FY 2022
Bruttomarge25,2 %28,3 %28,7 %27,3 %29,9 %
Operative Marge7,3 %10,4 %11,2 %8,8 %10,8 %
Nettomarge1,8 %8,4 %10,0 %7,6 %6,7 %
KGV31,67,27,27,27,8
Kurs-Umsatz-Verhältnis0,60,60,70,50,5
Kurs-Buchwert-Verhältnis0,91,01,11,00,9
Verschuldungsgrad0,90,80,81,11,0
Liquidität 3. Grades2,01,92,01,82,3
Dividendenrendite4,9 %4,3 %3,2 %3,6 %3,9 %
Unternehmenswert557,44 Mrd.574,81 Mrd.635,36 Mrd.521,09 Mrd.440,61 Mrd.
EV/EBITDA7,75,35,75,95,8
Eigenkapitalrendite2,9 %13,7 %15,6 %13,8 %11,5 %
Kapitalrendite (ROIC)2,6 %6,9 %6,5 %5,5 %5,9 %
Free-Cashflow-Rendite0,8 %6,6 %2,7 %−7,0 %−0,2 %

Wachstum

FY 2026FY 2025FY 2024FY 2023FY 2022
Umsatz−1,2 %+5,1 %+3,7 %+15,0 %+18,9 %
Bruttogewinn−11,8 %+3,4 %+9,1 %+5,3 %+23,1 %
Operatives Ergebnis−31,0 %−2,2 %+31,3 %−6,3 %+54,5 %
Nettogewinn−79,4 %−11,4 %+37,2 %+30,2 %+58,5 %
Gewinn je Aktie−78,6 %−8,2 %+42,3 %+33,3 %+59,8 %
Freier Cashflow−89,3 %+111,0 %+154,1 %−3.999,6 %−102,2 %
Dividende je Aktie+8,9 %+22,3 %+25,1 %+13,1 %−6,7 %

Analysten

Einstufungen

Gerade nicht verfügbar.

Kursziel

Gerade nicht verfügbar.

Schätzungen

FY 2027FY 2028FY 2029
Umsatz (Ø)621,27 Mrd.634,83 Mrd.666,86 Mrd.
Umsatz (Tief – Hoch)601,72 Mrd. – 652,87 Mrd.607,15 Mrd. – 671,73 Mrd.633,73 Mrd. – 702,7 Mrd.
Gewinn je Aktie (Ø)137,88148,24178,65
Gewinn je Aktie (Tief – Hoch)106,59 – 161,23110,59 – 180,96144,18 – 210,21
Analysten887

Quartalszahlen

Nächste Zahlen: 3. Feb. 2027
Nov. 2026Juli 2026Mai 2026Feb. 2026Nov. 2025Aug. 2025Mai 2025Feb. 2025
Gewinn je Aktie · Erwartet30,7921,4651,8850,2158,9034,9242,5757,00
Gewinn je Aktie · Tatsächlich35,7736,65-96,2464,0934,6136,2921,1444,12
Abweichung+16,17 %+70,78 %−285,51 %+27,64 %−41,24 %+3,92 %−50,34 %−22,60 %
Umsatz · Tatsächlich160,46 Mrd.152,38 Mrd.154,81 Mrd.147,71 Mrd.137,85 Mrd.139,27 Mrd.153,99 Mrd.142,86 Mrd.

Dividenden und Splits

Ex-TagZahltagBetrag
30. März 202730. März 202740,00
29. Sept. 20262. Dez. 202635,00
30. März 202622. Juni 202630,00
29. Sept. 20252. Dez. 202530,00
28. März 202523. Juni 202530,00
27. Sept. 20243. Dez. 202430,00
28. März 202424. Juni 202425,00
28. Sept. 20234. Dez. 202325,00
30. März 202326. Juni 202320,00
29. Sept. 20222. Dez. 202218,00
30. März 202223. Juni 202216,00
29. Sept. 20212. Dez. 202116,00

Aktiensplits

–

Eigentümer

Institutionen

Gerade nicht verfügbar.

Insider-Geschäfte

–

Vergleichbare Unternehmen

Über das Unternehmen

Daicel Corporation, a Japanese enterprise founded in Osaka in 1919, conducts its business operations across Japan, Asia, North America, and Europe. The company is a key producer and distributor of a broad array of products, including cellulosic derivatives, organic chemicals, diverse plastics, and pyrotechnic devices. Its extensive activities are organized into distinct segments: Medical/Healthcare, Smart, Safety, Materials, Engineering Plastics, and other specialized areas. In the Medical/Healthcare sector, Daicel supplies various cosmetic components such as 1,3-Butylene glycol, polyglycerin, and thickeners, in addition to natural health food ingredients and dietary supplements. For the pharmaceutical industry, it provides specialized chiral and achiral columns, a variety of chiral and bio reagents, and DNA/RNA-based probes, supported by comprehensive analytical, purification, synthesis, formulation, and specialized analytical tool services. The "Smart" segment focuses on advanced materials for the electronics industry, offering triacetylcellulose and films for display technologies, solvents for electronic applications, polymers for resist processes, and cleaning agents for semiconductors. Moreover, Daicel contributes to visualization technologies with its optical components, lens units, silver nanoparticle inks, and organic semiconductor devices. Within the Safety domain, the company manufactures inflators for vehicle airbags and pyro-fuses, alongside safety mechanisms for non-automotive products. Daicel is also a significant supplier of foundational chemicals and raw materials, including acetic acid and its derivatives, cellulose acetate, and acetate tow for resins, inks, and paint solvents. It further develops specialty chemicals such as cycloaliphatic epoxies, caprolactone, ketene derivatives, and alkylamines, which are vital for electrical materials and coatings. For the Engineering Plastics segment, Daicel delivers a wide selection of plastic solutions, encompassing engineering plastics, plastic compound products, functional sheets, molded trays, and packaging films. Beyond these core offerings, the company also produces water treatment systems and diffusers tailored for diverse industrial requirements. Daicel's comprehensive portfolio plays a crucial role in various sectors, including transportation, electronics, medical care, personal care, daily life, and environmental and energy applications. The company, which was initially named Daicel Chemical Industries, Ltd., officially adopted its current name, Daicel Corporation, in October 2011.

Führung

  • Yoshimi OgawaExecutive Board Chairman
  • Yasuhiro SakakiPresident, Chief Executive Officer & Director
  • Kotaro SugimotoSenior Managing Executive Officer, Head of Corporation Support HQ & Representative Director
  • Naotaka KawaguchiSenior Managing Executive Officer, Senior Managing Executive Officer & Director & Director
  • Seiji YamakadoExecutive Officer & Head of Customer Center
  • Takashi MiyamotoSenior Managing Executive Officer
CEO
Yasuhiro Sakaki
Mitarbeitende
11.034
Hauptsitz
Osaka, OS, JP
Sektor
Basic Materials
Branche
Chemicals - Specialty
Börsengang
1. Jan. 2001
Website
daicel.com

Nachrichten

Gerade keine Nachrichten zu diesem Unternehmen.

Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.